Stay updated on ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Removal of the 403 Forbidden HTML block and Home link indicates the previous access error is resolved and the page is positioned to display its standard content.
    Difference
    0.5%
    Check dated 2026-09-26T18:32:04.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed when attempting to view the study record, replacing the expected content with an access-restricted message. This indicates the page is blocked and the study details are not accessible at this time.
    Difference
    20%
    Check dated 2026-09-19T21:51:29.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    A 2014 U.S. NIH Grant/Contract note was added and the page revision updated to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T19:58:54.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page's Revision tag has been updated from v3.6.4 to v3.6.5, indicating a newer build of the page. This is a metadata update and does not change the study information shown.
    Difference
    0.0%
    Check dated 2026-08-08T20:54:20.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.3 to v3.6.4, indicating a minor maintenance update to the page. This does not reflect a substantive change to study details or content.
    Difference
    0.0%
    Check dated 2026-07-25T12:57:23.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Added a publication citation (Horinouchi et al.) to the study Publications section describing a phase Ib study of telisotuzumab vedotin with osimertinib in c-Met–expressing NSCLC, and updated the revision tag from v3.6.2 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-03T23:55:31.000Z thumbnail image

Stay in the know with updates to ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.